Skip to main content

Table 5 Summary of studies using ferrets, cat, and dog models of SARS-CoV-2 infection

From: Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review

Species (ref)

Number age (gender)

Virus strain dose* (inoculation route)†

Clinical signs & observation duration (DPI)§

Viral replication‡ (DPI)

Pathology & sacrificing date (DPI)

Immune response

Seroconversion (DPI)

Outcome measures

Ferrets

n = 12

NMC-nCoV02/Korea

Increased body temperature

Nose, saliva, urine, and feces

Acute bronchiolitis

NA‡

IgG and serum-neutralizing antibody response against SARS-CoV-2 (12)

Pathogenesis of COVID-19

Infiltrates of immune cells and debris (4)

12–20 months

105.5 TCID50

Reduced activity `

 

(4, 8, 12)

Assess viral transmission

M/F

IN

occasional coughs

(12)

Trachea, lung, kidney, serum, and intestine (2)

n = 12

Control

NO

(12)

NO

NO

(4, 8, 12)

NO

NO

12–20 months

 

M/F

 

Kim et al. (2020) [60]

n = 6

(naïve direct contact)

Direct contact

Increased body temperature

(12)

All animals were infected (2)

(12)

 

IgG and serum-neutralizing antibody response against SARS-CoV-2 (12)

n = 6

(naïve indirect contact)

Indirect contacts

No increased body temperature

(12)

Nose, feces (2 out of 6 animals)

(4)

(12)

 

IgG antibody response against SARS-CoV-2 (12)

Serum-neutralizing antibody response in 1 out of 6

Ferrets

Blanco-Melo et al. (2020) [61]

n = 6

USA-WA1/2020

NA

(14)

Nose, trachea

NA

(3, 14)

Reduced interferon type I and III response

NA

Host interferon response

4 months

5 × 104 PFU

(3,7)

 

Castrated male

IN

 

Increase proinflammatory chemokines and cytokines response

Ferrets

Richard et al. (2020) [62]

n = 4

BetaCoV/Munich/BavPat1/2020

NA

(21)

Nose, throat, rectum

NA

(21)

NA

IgG antibody response against SARS-CoV-2 (21)

Viral transmission

6 months (F)

6.105 TCID50

Donor

IN

n = 4

6 h post-inoculation co-housed with donor

NA

(21)

Nose, throat, rectum (1)

NA

(21)

NA

IgG antibody response against SARS-CoV-2 (21)

6 months (F)

direct contact

n = 4

1 dpi placed in an opposite cage (10 cm) of donor

NA

(21)

Nose, throat, rectum (3)

NA

(21)

NA

IgG antibody response against SARS-CoV-2 (21)

6 months (F)

Indirect contact

Ferrets

n = 10

SARS-CoV-2 /F13/environment/2020/Wuhan

Fever

Nose, throat, and rectum (low titer) (4–8)

Severe lymphoplasmacytic, perivasculitis

 

IgG antibody response against SARS-CoV-2 (13)

Pathogenesis of COVID-19

3–4 months

F

 

Loss of appetite

(20)

 

Vasculitis

NA

SARS-CoV2/CTan/human/2020/Wuhan]

  

Increased type II pneumocytes, macrophages, and neutrophils in the alveolar septa and alveolar lumen.

105 PFU

  

Mild peribronchitis (13)

IN

  

(4, 20)

n = 8

SARS-CoV2/CTan/human/2020/Wuhan]

NA

(14)

Nose, throat

(2–8)

NA

(2, 4, 8, 14)

NA

NA

3–4 months

105 PFU

F

IT

Cats

n = 10

SARS-CoV-2 /CTan/human/2020/Wuhan

NA

(20)

Nose, soft palate, tonsil, trachea, lungs, and small intestines.

NA

(3, 6, 10, 20)

NA

IgG antibody response against SARS-CoV-2 (10)

6–9 months

105 PFU

M\F

IN

Sub-adult

n = 10

SARS-CoV-2 /CTan/human/2020/Wuhan

One cat died (3)

(12)

Nose, soft palate, tonsil, trachea, lungs, and small intestines.

Extensive nasal, tonsil, tracheal, lung, and small intestine epithelial mucosal lesions (3)

(3, 6, 11,12)

NA

IgG antibody response against SARS-CoV-2 (10)

70–100 days

105 PFU

M/F

IN

Juvenile

Dogs

n = 5

SARS-CoV-2-2/CTan/human/2020/Wuhan

NA

Rectum (2/5)

NA

NA

IgG antibody response against SARS-CoV-2 (14)

3-month beagles

105 PFU

IN,

Shi et al. (2020) [63]

n = 2

Exposed to donor

NA

No

NA

NA

No

3 month

Beagles

  1. *TCID50 Median Tissue Culture Infectious Dose at which 50% of the cells are infected, PFU plaque-forming unit, †IT intratracheal, IN intranasal, CJ intraconjunctival, OC ocular, IG intragastric, PO per oral, IP intraperitoneal, ‡ viral replication RNA copies (PCR), viral antigen (immunostaining), viral particles (electron microscopy), § dpi day post-inoculation